These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 23371873)
1. [Anticoagulation and atrial fibrillation]. Simmers TA Tijdschr Gerontol Geriatr; 2012 Dec; 43(6):308-12. PubMed ID: 23371873 [TBL] [Abstract][Full Text] [Related]
2. Stroke prevention in atrial fibrillation: do we still need warfarin? Diener HC; Weber R; Lip GY; Hohnloser SH Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201 [TBL] [Abstract][Full Text] [Related]
3. New pharmacotherapy for stroke prevention in atrial fibrillation: update 2010. Armaganijan L; Eikelboom J; Healey JS; Morillo CA Adv Ther; 2009 Dec; 26(12):1058-71. PubMed ID: 20127214 [TBL] [Abstract][Full Text] [Related]
4. Prevention of cardioembolic stroke in patients with atrial fibrillation. Weber R; Diener HC; Weimar C Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1405-15. PubMed ID: 20936927 [TBL] [Abstract][Full Text] [Related]
5. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
6. The impact of comorbidities on stroke prophylaxis strategies in atrial fibrillation patients. Somberg JC Am J Ther; 2011 Nov; 18(6):510-7. PubMed ID: 22072096 [TBL] [Abstract][Full Text] [Related]
7. New anticoagulants for the prevention of stroke in atrial fibrillation. Höchtl T; Huber K Fundam Clin Pharmacol; 2012 Feb; 26(1):47-53. PubMed ID: 21883447 [TBL] [Abstract][Full Text] [Related]
8. New anticoagulants for atrial fibrillation. De Caterina R; Kristensen SD; Renda G J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276 [TBL] [Abstract][Full Text] [Related]
9. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke. Martí-Fàbregas J; Mateo J Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840 [TBL] [Abstract][Full Text] [Related]
11. Stroke prevention in atrial fibrillation patients. Marinigh R; Lip GY; Lane DA Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589 [TBL] [Abstract][Full Text] [Related]
12. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm. Chaudhari D; Bhuriya R; Arora R Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986 [TBL] [Abstract][Full Text] [Related]
13. Ineligibility for anticoagulation in patients with atrial fibrillation. del Conde I; Halperin JL Am J Med; 2013 Feb; 126(2):105-11. PubMed ID: 23331435 [TBL] [Abstract][Full Text] [Related]
14. Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Poli D; Antonucci E; Testa S; Ageno W; Palareti G; Thromb Res; 2013 Jan; 131(1):12-6. PubMed ID: 23141847 [TBL] [Abstract][Full Text] [Related]
15. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease. Turagam MK; Addepally NS; Velagapudi P Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1297-9. PubMed ID: 24138517 [TBL] [Abstract][Full Text] [Related]
16. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516 [TBL] [Abstract][Full Text] [Related]